PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.\', \'Department Emergency Medicine, George Washington University School of Medicine, Washington, DC, USA.\', \'Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA; Department of Epidemiology, University of North Carolina at Chapel Hill School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.\', \'Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.\', \'Department Emergency Medicine, George Washington University School of Medicine, Washington, DC, USA. Electronic address: jlafleur@mfa.gwu.edu.\', \'Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA. Electronic address: Prem@med.unc.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S2211-1247(22)00052-310.1016/j.celrep.2022.110336
?:doi
?:hasPublicationType
?:journal
  • Cell reports
is ?:pmid of
?:pmid
?:pmid
  • 35090596
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.552
?:rankingScore_hIndex
  • 92
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all